Traduction de «patients with stable coronary artery » (Français → Néerlandais) :

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bl Lancet 362 : 782-788(2003)
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bli Lancet 362 : 782-788(2003)

J. Hypertension 21, 1771- 1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.
J. Hypertension 21, 1771-1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

les antécédents du patient (insuffisance rénale, transplantation rénale et/ou dialyse, accident cérébrovasculaire/accident ischémique transitoire/infarctus du myocarde, Intervention Coronaire Percunanée (ICP) ou Coronary Artery Bypass Graft (CAGB), revascularisation des membres inférieurs, amputation mineure, amputation majeure, lésion diabétique au(x) pied(s), par qui/quelle instance le patient a-t-il été référé (médecin (1 ère ou 2 ème ligne), praticien paramédical, par une autre clinique du pied, initiative du patient));
antecedenten van de patiënt (nierinsufficiëntie, niertransplantatie en/of dialyse, cerebrovasculair accident / transitoir ischemisch accident / myocardinfarct, percutane coronaire interventie (PCI-) of Coronary Artery Bypass Graft (CABG), revascularisatie van de onderste ledematen, mineure amputatie, majeure amputatie, diabetische voetletsels, door wie / welke instantie werd de patiënt doorverwezen (arts (1ste lijn of 2de lijn), paramedicus, andere voetkliniek, initiatief van de patiënt);

Lancet 362, 782-788 (2003) H.D. White: Should all patients with coronary disease receive angiotensin-convertingenzyme inhibitors?
Lancet 362, 782-788 (2003) H.D. White: Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

Les Pfizer Awards 2008 étaient destinés au Professeur Ingeborg Stalmans de la KULeuven pour son travail de recherche intitulé “The effect of atorvastatine (Lipitor®) on intraocular pressure and ocular blood flow in patients with glaucoma” et pour le Dr. Steven Heireman de l’UGent pour son travail “Structural and functional arterial properties in normal-tension glaucoma”.
De 2008 Pfizer Awards waren bestemd voor Professor Ingeborg Stalmans van de KULeuven voor haar onderzoekswerk “The effect of atorvastatine (Lipitor®) on intraocular pressure and ocular blood flow in patients with glaucoma” en voor Dr. Steven Heireman van het UGent voor zijn werk rond “Structural and functional arterial properties in normal-tension glaucoma”.

Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric and abdominal aortic): Executive summary.
2011: Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease.

36. McKevitt FM, Macdonald S, Venables GS, Cleveland TJ, Gaines PA. Complications following carotid angioplasty and carotid stenting in patients with symptomatic carotid artery disease.
following carotid angioplasty and carotid stenting in patients with symptomatic carotid artery disease.

32. Kastrup A, Schulz JB, Raygrotzki S, Groschel K, Ernemann U. Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients.
angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients.

Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial.
Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S et al. Oral anticoagulant and antiplatelet tjerapy and peripheral arterial disease.

Update 2011: Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease.
Scottish Intercollegiate Guidelines Network. Diagnosis and management of peripheral arterial disease.